Phage Focus: Revisiting our BAFASAL® Research
Our research, published in 2020 in Viruses (MDPI), titled ‘Comprehensive Evaluation of the Safety and Efficacy of BAFASAL® Bacteriophage Preparation for the Reduction of Salmonella
2024: A Year of Progress and Innovation at Proteon Pharmaceuticals
We are pleased to share the significant progress Proteon Pharmaceuticals made in 2024. Our company strengthened its market position, advanced its research initiatives, and expanded
Proteon Pharmaceuticals Enhances Portfolio with BAFASAL PRO Registration in Brazil
Proteon Pharmaceuticals is delighted to announce that the Ministry of Agriculture, Livestock Farming and Supplies (MAPA) in Brazil has registered BAFASAL PRO, our latest bacteriophage-based
Breaking News: EFSA Confirms BAFASAL®’s Efficacy in Poultry Production
Proteon Pharmaceuticals is excited to announce that the European Food Safety Authority (EFSA) has published a positive scientific opinion on our innovative product BAFASAL®. The
From Classroom to Lab: Student Interns Reflect on Their Experience at Proteon Pharmaceuticals
At Proteon Pharmaceuticals S.A., we’re dedicated to supporting the growth of future scientists and professionals. This summer, we offered the internships to six students, eager
Proteon Pharmaceuticals Receives European Patent for Innovative Poultry Diagnostic Method
Proteon Pharmaceuticals is thrilled to announce the obtaining of a new European patent for our pioneering technology: “Method and Kit for Detection of Extraintestinal E.